Texas to invest in drug delivery company

> Texas is going to invest $9.2 million from its Texas Emerging Technology Fund into three companies spun out of InCube Labs. Among them is Fe3 Medical, which will get $2.8 million to commercialize drug delivery technology that enables the safe, non-toxic transport of about 10 mg of iron across the skin for sufferers of iron-deficiency anemia. Report

> pSivida, a Watertown, Mass.-based ophthalmic drug-delivery device maker, saw a 388 percent increase in revenues during the fourth quarter of fiscal 2010. Report | But you read it here first

> Writing in the journal Nanobiotechnology, researchers say they have developed a novel drug delivery system to provide sustained delivery of CF "correctors" and "anti-inflammatories" to the lungs, demonstrating a promising treatment for cystic fibrosis. Abstract

> Johns Hopkins University researchers have developed tiny drug-delivery tools that could be introduced into the human body and can change shape on command--clamping shut or popping open in response to specific chemical cues. Report
 
> Drug delivery patent application of the week: Medical Devices Having Nanoporous Coatings for Controlled Therapeutic Agent Delivery Patent Application. Patent application
 
> Drug delivery science abstract of the week: Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays. Abstract

> Drug delivery tweet of the week: DrugDelivery helps save lives. Do you want that success on your conscience? New Product Engineer. Posting | Tweet

Suggested Articles

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.

Alexion's 100 mg/ml Ultomiris formulation is expected to slash infusion times by about 60% and bodes well for a planned subcutaneous version, too.